HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS CONFERENCE CALENDAR
LATEST UPDATES » Vol 21, No 06, June 2017 – Advocacies in Support of Rare Disease Patients       » Bayer and NUS Enterprise Announce Winners of Grants4Apps? Singapore Open Innovation Challenge       » Cancer Control Efforts in Vietnam: Interview with Dr Tran Thanh Huong       » China Sets up National Lab Developing Brain-Like AI Technology       » New Womb-Like Invention for Preterm Infants       » World Asthma Day: Managing and Living with Asthma       » Managing Liver Cancer as a Global Health Problem      
EYE ON CHINA
BGI Partners with NRGene to Provide Broadest Genomic Analysis Available

Ness Ziona, Israel, and Shenzhen, China, August 15, 2016 – BGI, the world’s largest omics organisation, announced today that it will be offering NRGene’s technology as part of its broad genomics analysis services in agriculture research.

BGI supports genomic research worldwide by offering a variety of genetic research and application technologies for the healthcare, agriculture, conservation, and environmental fields. It also publishes the respected international research journal, GigaScience, to further contribute to the genomics community.

NRGene provides genomic assessment and assembly tools that solve the most complex genomic challenges accurately and rapidly. Most recently, NRGene mapped the bread and pasta wheat genomes, which represent the most complex genomes to assemble, in mere weeks rather than years.

“We have recognised the complementary capabilities that NRGene’s and BGI’s technologies provide to the Chinese genomics community, with its wide and diverse challenges,” said Gao Qiang, CEO of BGI Tech. “The combined technologies will transform Asian agriculture.”

NRGene’s DeNovoMAGICTM 2.0 delivers the most accurate reference genomes fast and cost effectively, while PanMAGICTM provides genome-to-genome mapping across varieties. It displays all types of sequence differences and structural variations within the studied genetic material including SNPs, InDels of any size, inversions, translocations, gene PAVs, and gene CNVs.

“Being a selected technology by the world’s leading omics group is a major step forward as we continue to disrupt the genomics industry,” said Dr. Gil Ronen, CEO, NRGene. “Our high quality genomic analysis is already advancing agricultural genomics, and this will help drive us into other markets that are primed to accelerate their research.”

Source: NRGene & K2 Global Comms

Click here for the complete issue.

NEWS CRUNCH  
news The Seventh International Meeting on Synthetic Biology (SB 7.0)
news Healthcare Sustainability in Asia: Now is the Time to Act — FT Asia Healthcare & Life Sciences Summit 2017
news Philip Morris International and British American Tobacco receive award from PETA science group for AOP developments
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  

Lady Ganga: Nilza'S Story
COLUMNS  
Subscribe to APBN E-Newsletter
Find us under 'Others' option to receive APBN e-newsletters thrice a month!

APBN Editorial Calendar 2017
January:
Healthcare Focus: LUNGS
February:
War on CANCER
March:
Get to Know TCM
April:
Diabetes: The Big Picture
May:
The Piece of Your Mind - Brain Health/Science
June:
Advocacies in Support of Rare Disease Patients
July:
Food Science & Technology
August:
Eye Care/ Eye Health
September:
Emerging Infectious Diseases
October:
No. 1 Killer — Heart Diseases
November:
Diseases threatening our Children
December:
Skin Diseases/Allergic Reactions
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Carmen
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2017 World Scientific Publishing Co Pte Ltd  •  Privacy Policy